Perfil das demandas judiciais de medicamentos no âmbito da Superintendência Regional de Saúde de Juiz de Fora - MG: aplicação de indicadores de avaliação e monitoramento

Abstract

The legitimacy by ensuring universal and integral right to health is the high number of judicial actions, including medicines against various spheres of management of the Unic Health System (SUS). Such demands have caused disruptions in S US management, creating even, parallel management policies, diversion of public funds to meet the injunctions. In order to know the characteristics of the plaintiffs, judicial actions and medicines requested remedy against the State Department of Health of the State of Minas Gerais, more specifically against the Regional Superintendent of Juiz de Fora Health (SRS / JF ), was conducted observational cross-sectional study of lawsuits drugs that deployed from october 2004 to october 2015. 574 initial processes requiring 929 drugs were analyzed. There was a predominance of females (63,3%) and living in the city of Juiz de Fora, headquarters of the SRS / JF. Approximately 59% of authors were attended by the public defender or attorney dative (the one named for her) and 88.3% had the defendant only the state of Minas Gerais. The most demanded drugs are belong to the Central Nervous System group (26,5%), according to ATC classification, immunosuppressants and (9,6%), antiepileptics (7,6%) and thrombotic agents (6,9%) the most demanded pharmacological subgroups. The most requested medications were etanercept (2,5%), quetiapine and rivaroxaban (2,2%) and oxcarbamazepina (1,9%). About 11,4% are present in the State List of Drugs for Mine Pharmacy Program: primary health care and 18,5% make up the specialized component and, as seen in other studies, requests are higher for those not belonging to official lists of public funding (70,.1%). The requested medications, 77,1% currently have therapeutic alternatives in the SUS. The use of the Monitoring and Evaluation Indicators Manual enabled the verification similarities and differences with other studies that have used or those with similar data for the present study. We believe that the trends serve as a subsidy for the reformulation of public policies with a view to expanding access to medicines, preserving the public administration and the right to health.